Probiotique+ (de longue conservation) - 2 mois d'approvisionnement
Delivers 35 billion CFU of live bacteria from 7 clinically validated strains for everyday gut health.
- 35 billion CFU of live bacteria in every capsule
- 7 targeted strains for microbiome diversity
- Science-led blend by an Expert Nutritionist
- Vegan + Shelf-Stable – no refrigeration required
- FREE Welcome Pack
- Rewards + gifts with every order
- FREE JSHealth App access
- Subscriber-only deal drops
- Subscriber-only e-books + guides
- Early access to sales + launches
- Cancel or reschedule anytime
- *Free Shipping Available For EU Orders Over €60
UP TO 25% OFF
+FREE SHIPPING*
"This is an amazing probiotic. It really works."
Nichole H.
The gut microbiome is a complex ecosystem of trillions of live bacteria that plays a foundational role in digestive balance and overall wellbeing. Diversity within this system is key, with different bacterial strains contributing to a resilient, well-functioning microbiome.
Each vegan-friendly capsule delivers 35 billion Colony Forming Units from 7 targeted strains, selected for their scientific backing. The formula is shelf-stable, meaning no refrigeration is required, making it easy to take consistently at home or while travelling.
Think of it as your gut health insurance, in the convenience of one capsule a day, every day!
Carefully formulated to care for you.
The JSHealth Probiotic+ formula contains Lactobacillus rhamnosus, Lactobacillus casei and Lactobacillus paracasei, along with other strains.
Active ingredients per capsule:
Lactobacillus paracasei (CUL08) 25.5 billion CFU
Bifidobacterium longum (CUL75) 3 billion CFU
Bifidobacterium lactis (HN019) 2.5 billion CFU
Bifidobacterium animalis subsp. lactis (CUL34) 1 billion CFU
Lactobacillus casei (CUL06) 1 billion CFU
Lactobacillus plantarum (CUL66) 1 billion CFU
Lactobacillus rhamnosus (CUL63) 1 billion CFU
(Live Bacteria Culture 35 billion CFU)
CFU= Colony-Forming Units.
Ingredients: Lactobacillus paracasei (CUL08), Bulking agent (Microcrystalline cellulose), Capsule shell (Hydroxypropyl methylcellulose), Bifidobacterium longum (CUL75), Bifidobacterium lactis (HN019), Anti-caking agents (Silicon dioxide, Magnesium stearate), Lactobacillus casei (CUL06), Lactobacillus rhamnosus (CUL63), Lactobacillus plantarum (CUL66), Bifidobacterium animalis subsp. lactis (CUL34).
Vegan formula. Does not contain crustacea, egg, fish, milk, peanut, sesame, soy, tree nut, animal products or artificial colours.
♻︎ All JSHealth Vitamins are recyclable in your normal household recycling. We use HDPE and PET recyclable plastic to reduce packaging waste. Please recycle your bottles.
Take 1 capsule daily with water.
- Do not exceed the recommended daily amount.
- Food supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle.
- If you are pregnant, breastfeeding, under medical supervision or taking any medication, consult a doctor before use.
- Store below 25°C in a cool, dry place away from direct heat and sunlight.
- Keep out of reach of children.
- The product is shelf-stable, but can also be refrigerated.
- Do not use if the cap seal is broken or missing.
This is an international product. Label text and ingredient formulations may vary slightly depending on the country of sale.
A considered, science-led approach to probiotic formulation, designed with precision and built for strength, simplicity and everyday consistency.
- High-strength delivery, providing 35 billion Colony Forming Units per capsule to support a robust daily beneficial bacteria intake
- 7 targeted strains, carefully selected to enhance bacterial diversity within the gut microbiome
- Once-daily capsule format, developed to support long-term consistency as part of a daily routine
- Designed in Australia by Expert Nutritionist, Jess Sepel, grounded in evidence-based nutritional principles and scientific research
QUALITY + CARE:
Our team of health experts source the ingredients in our products with great care. We ensure quality actives are placed in each of our targeted formulas to achieve its indications.
We believe in nourishing your health, confidence and wellbeing with a holistic approach.
The indications behind our chosen probiotic strains:
Bifidobacterium lactis:
2.5 billion CFU
- Maintains and supports intestinal beneficial flora
- Maintains and supports healthy digestive system function
- Maintains and supports bowel regularity
- Maintains and supports healthy immune system function
- Maintains and supports healthy gastrointestinal function
- Maintains and supports gastrointestinal system health
- Maintains and supports intestinal health
Bifidobacterium animalis ssp lactis:
1 billion CFU
- Maintains and supports intestinal health
- Maintains and supports healthy digestion
- Maintains and support gastrointestinal system health
Bifidobacterium longum:
3 billion CFU
- Maintains and supports intestinal beneficial flora
- Maintains and supports healthy digestion
- Maintains and supports gastrointestinal system health
- Maintains and supports intestinal health
Lactobacillus rhamnosus:
1 billion CFU
- Maintains and supports healthy digestion
- Maintains and supports gastrointestinal system health
- Maintains and supports intestinal health
Lactobacillus paracasei
25.5 billion CFU
- Maintains and supports intestinal health
- Maintains and supports gastrointestinal system health
Lactobacillus plantarum
1 billion CFU
- Maintains and supports intestinal health
- Maintains and supports gastrointestinal system health
Lactobacillus casei
1 billion CFU
- Maintains and supports intestinal health
- Maintains and supports gastrointestinal system health
The science and research behind our chosen probiotic strains:
Bifidobacterium lactis Studies
- Ahmed, M., Prasad, J., Gill, H., Stevenson, L. and Gopal, P., 2007. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects. Journal of Nutrition, Health and Aging, 11(1), pp.26–31. View here.
- Gill, H.S., Rutherfurd, K.J., Cross, M.L. and Gopal, P.K., 2001. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. American Journal of Clinical Nutrition, 74(6), pp.833–839. View here.
Bifidobacterium animalis ssp lactis Studies
- Eskesen, D., Jespersen, L., Michelsen, B., Whorwell, P.J., Müller-Lissner, S. and Morberg, C.M., 2015. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. British Journal of Nutrition, 114(10), pp.1638–1646. doi:10.1017/S0007114515003347. View here.
- Jungersen, M., Wind, A., Johansen, E., Christensen, J.E., Stuer-Lauridsen, B. and Eskesen, D., 2014. The science behind the probiotic strain Bifidobacterium animalis subsp. lactis BB-12®. Microorganisms, 2(2), pp.92–110. doi:10.3390/microorganisms2020092. View here.
- Miller, L.E., Lehtoranta, L. and Lehtinen, M.J., 2017. The effect of Bifidobacterium animalis ssp. lactis HN019 on cellular immune function in healthy elderly subjects: systematic review and meta-analysis. Nutrients, 9(3), p.191. View here.
Bifidobacterium longum Studies
- Odamaki, T., Sugahara, H., Yonezawa, S., Yaeshima, T., Iwatsuki, K., Tanabe, S., Tominaga, T., Togashi, H., Benno, Y. and Xiao, J., 2012. Effect of the oral intake of yogurt containing Bifidobacterium longum BB536 on the cell numbers of enterotoxigenic Bacteroides fragilis in microbiota. Anaerobe, 18(1), pp.14–18. doi:10.1016/j.anaerobe.2011.11.004. View here.
- Lau, A.S.-Y., Yanagisawa, N., Hor, Y.-Y., Lew, L.-C., Ong, J.-S., Chuah, L.-O. and Liong, M.-T., 2018. Bifidobacterium longum BB536 alleviated upper respiratory illnesses and modulated gut microbiota profiles in Malaysian pre-school children. Beneficial Microbes, 9(1), pp.61–70. doi:10.3920/BM2017.0063. View here.
- Toscano, M., De Grandi, R., Stronati, L., De Vecchi, E. and Drago, L., 2017. Effect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level: a preliminary study. World Journal of Gastroenterology, 23(15), pp.2696–2704. doi:10.3748/wjg.v23.i15.2696. View here.
Lactobacillus rhamnosus Studies
- Toscano, M., De Grandi, R., Stronati, L., De Vecchi, E. and Drago, L., 2017. Effect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level: a preliminary study. World Journal of Gastroenterology, 23(15), pp.2696–2704. doi:10.3748/wjg.v23.i15.2696. View here.
Targeted ingredients
Real reviews, real results
Individual results may vary.